State of the art: 40 years of percutaneous cardiac intervention

Robert A. Byrne; Davide Capodanno; Darren Mylotte; Patrick W. Serruys

doi:10.4244/eijv13i6a98

Related publications

Article2022

Coronary Physiology as Part of a State-of-the-Art Percutaneous Coronary Intervention Strategy

Asad Shabbir, Alejandro Travieso, Hernán Mejía‐Rentería, Carolina Espejo‐Paeres, Nieves Gonzalo, Adrian Banning, Patrick W. Serruys, Javier Escaned

Interventional Cardiology Clinics

Article2023

Coronary Physiology as Part of a State-of-the-Art Percutaneous Coronary Intervention Strategy

Asad Shabbir, Alejandro Travieso, Hernán Mejía‐Rentería, Carolina Espejo‐Paeres, Nieves Gonzalo, Adrian Banning, Patrick W. Serruys, Javier Escaned

Cardiology Clinics

Article2006

Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention

Patrick W. Serruys, Pim de Feyter, Carlos Macaya, N. Kokott, Jean‐Luc Puel, Matthias Vrolix, Angelo Branzi, Marcelo Chiara Bertolami, Graham Jackson, Bradley H. Strauss, Bernhard Meier

Article2003

Fluvastatin prevents cardiac events following successful percutaneous coronary intervention in patients with multivessel disease: The lescolfi intervention prevention study

Pedro A. Lemos, G. Boxho, Dick Goedhart, Brian J. O’Neil, J. P. Broustet, Gunnar H. Berghoefer, C. Alonso, A. Boehmer, Pim de Feyter, Patrick W. Serruys

Journal of the American College of Cardiology

Article2001

Selectice laser sintering: state-of-the-art

Jean-pierre Kruth, Tahar Laoui

International Journal of Electrical Machining

State of the art: 40 years of percutaneous cardiac intervention

Abstract

Discussion(0)

Related publications

Coronary Physiology as Part of a State-of-the-Art Percutaneous Coronary Intervention Strategy

Coronary Physiology as Part of a State-of-the-Art Percutaneous Coronary Intervention Strategy

Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention

Fluvastatin prevents cardiac events following successful percutaneous coronary intervention in patients with multivessel disease: The lescolfi intervention prevention study

Selectice laser sintering: state-of-the-art